1. Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer. (11th December 2017) Authors: Condorelli, R; Spring, L; O'Shaughnessy, J; Lacroix, L; Bailleux, C; Scott, V; Dubois, J; Nagy, R J; Lanman, R B; Iafrate, A J; Andre, F; Bardia, A Journal: Annals of oncology Issue: Volume 29:Number 3(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗